Vitro Lung Model Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2032
17.5%
CAGR (2026-2032)
590.08 USD Mn.
Forecast Market Size
319
Report Pages
155
Market Tables
Overview
The In Vitro Lung Model Market size was valued at USD 590.08 million in 2025 and is expected to reach USD 1824.63 million by 2032, at a CAGR of 17.5% during the forecast period.
To know about the Research Methodology :- Request Free Sample Report
In Vitro Lung Model Market Overview
In vitro models of the human lung served as advanced research platforms for large-scale screening, molecular-level analysis of cell–cell interactions, and the development of personalized treatment approaches for lung disorders. These models supported improved disease understanding and therapeutic innovation by replicating key aspects of human lung physiology under controlled laboratory conditions.
The report presented market estimates and forecasts for the global In Vitro Lung Model Market at both global and regional levels. The study covered the period from 2023 to 2029, with 2022 as the base year and 2017–2022 included as historical data.
The analysis provided a comprehensive assessment of market growth in terms of revenue (US$ Mn) across key geographies, including North America (NA), Europe (EU), Asia Pacific (APAC), the Middle East & Africa (MEA), and Latin America (LATAM).
The report delivered both qualitative and quantitative insights into industry trends, along with a detailed evaluation of market size and growth rates across all segments. The market was segmented based on Type, Application, and Region.
Key players operating in the global In Vitro Lung Model Market included Epithelix, MatTek Corporation, Lonza, ATCC, InSphero, Emulate, AlveoliX AG, Oncotheis, TissUse, Mimetas, CN Bio Innovations, Thermo Fisher Scientific Inc., PromoCell GmbH, Merck KGaA, and Horizon Discovery Group plc.
In Vitro Lung Model Market Dynamics
Significant physiological differences between animal and human lungs created a strong demand for human-relevant lung model systems to complement animal studies and enhance understanding of human respiratory biology.
The rising prevalence of lung fibrosis, emphysema, lung cancer, and other respiratory disorders accelerated research activities focused on in vitro lung models. These systems enabled researchers to accurately replicate complex aspects of human lung biology, generating opportunities for market growth by improving insights into cellular mechanisms and disease progression.
The increasing focus on cell biology and biochemistry research further supported market expansion. In vitro lung models strengthened the ability to evaluate disease pathways and therapeutic responses, thereby contributing to advancements in respiratory disease treatment and personalized medicine approaches.
In Vitro Lung Model Market Segment Analysis:
By Model Type, In the Global In Vitro Lung Model Market, 3D lung cell models dominated in 2025 due to their superior physiological relevance compared to traditional 2D cultures. These models better replicate lung microarchitecture, enabling more accurate drug efficacy and toxicity testing. Growing demand for predictive preclinical models in respiratory drug development further strengthened the leadership of 3D systems.
By Application, Within the Global In Vitro Lung Model Market, drug discovery and development held the largest share in 2025, driven by increasing R&D investments in respiratory therapies. Pharmaceutical companies are adopting advanced in vitro models to reduce animal testing and improve clinical success rates. The rising prevalence of asthma, COPD, and pulmonary infections continues to accelerate segment growth.
In Vitro Lung Model Market Regional Analysis:
North America commanded the largest market share of 38.2% by 2032.
North America led the Global In Vitro Lung Model Market in 2025, supported by strong research funding, advanced biotechnology infrastructure, and early adoption of organ-on-chip technologies. The presence of leading pharmaceutical companies and academic research institutions contributes significantly to regional revenue. Favorable regulatory frameworks promoting alternatives to animal testing further strengthen the region’s leadership.
Recent Industry Developments (2025–2026)
| Exact Date | Company | Development | Impact |
|---|---|---|---|
| 11 February 2026 | InSphero | The company formed a strategic partnership with PharmaNest to advance translational research in pulmonary and liver fibrosis. | This collaboration integrates 3D in vitro models with digital pathology to enhance the quantification of fibrotic progression in drug testing. |
| 12 February 2026 | Emulate, Inc. | The Airway Lung-Chip reached the final stage of the FDA’s ISTAND program for regulatory-facing validation. | It establishes the Organ-on-a-Chip platform as a primary tool for measuring inhaled drug permeability without animal testing. |
| 15 December 2025 | MIMETAS | The company commercialized advanced OrganoPlate lung models featuring integrated microvascular networks and immune-competent cells. | The platform enables high-throughput screening of drugs by simulating blood vessel interactions within human lung tissue. |
| 11 November 2025 | InSphero | The company expanded its 3D portfolio through the acquisition of DOPPL SA and Sun Bioscience’s Gri3D® technology. | This acquisition bolsters automated organoid production, significantly increasing the scalability of lung and liver 3D models. |
| 24 September 2025 | Georgia Tech / Nature | Researchers published a breakthrough immune-competent lung-on-a-chip that successfully mounted a defensive immune response to viral threats. | The model provides a new pathway to study severe influenza and inflammation spread in a physiologically active human environment. |
| 25 July 2025 | UBC Okanagan | Scientists developed a 3D bio-printed lung model utilizing a specialized hydrogel bioink to replicate human airway complexity. | This development allows for personalized medicine research by isolating and printing cells from patient-derived lung tissue. |
Vitro Lung Model Market Scope:Inquire before buying
| Global In Vitro Lung Model Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 590.08 USD Mn. |
| Forecast Period 2026-2032 CAGR: | 17.5% | Market Size in 2032: | 1824.63 USD Mn. |
| Segments Covered: | by Model Type | 3D Lung Cell Models 2D Lung Cell Models Lung-on-a-chip Models Air–Liquid Interface (ALI) Models |
|
| by Application | Drug Discovery & Development Toxicology & Safety Assessment Disease Modeling & Mechanism Studies Precision Medicine & Personalized Therapy Other Applications |
||
| by End User | Pharmaceutical & Biotechnology Companies Academic & Research Institutes Contract Research Organizations (CROs) Medical Device Manufacturers Others |
||
| by Technology Platform | Microphysiological Systems (MPS) Static Cell Cultures Bioprinting-based Models Others |
||
In Vitro Lung Model Market, by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)
Key Players/Competitors Profiles Covered in Brief Global In Vitro Lung Model Market Report in Strategic Perspective
- Epithelix Sàrl
- MatTek Corporation
- Lonza
- ATCC (American Type Culture Collection)
- InSphero AG
- Emulate, Inc.
- AlveoliX AG
- Mimetas BV
- TissUse GmbH
- CN Bio Innovations Ltd
- PromoCell GmbH
- Charles River Laboratories International, Inc.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- SynVivo Inc.
- Hesperos, Inc.
- Nortis, Inc.
- AxoSim Technologies LLC
- Newcells Biotech
- ImmuONE
- STEMCELL Technologies Inc.
- VITROCELL Systems GmbH
- Kirkstall Ltd
- React4Life Srl
- BEOnChip SL
Table of Contents
1. Global In Vitro Lung Model Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Global Global In Vitro Lung Model Market: Competitive Landscape
2.1. MMR Competition Matrix
2.2. Competitive Landscape
2.3. Key Players Benchmarking
2.3.1. Company Name
2.3.2. Business Segment
2.3.3. End-user Segment
2.3.4. Revenue (2025)
2.3.5. Company Locations
2.4. Leading Global In Vitro Lung Model Market Companies, by market capitalization
2.5. Market Structure
2.5.1. Market Leaders
2.5.2. Market Followers
2.5.3. Emerging Players
2.6. Mergers and Acquisitions Details
3. Global In Vitro Lung Model Market: Dynamics
3.1. Global In Vitro Lung Model Market Trends by Region
3.1.1. North America Global In Vitro Lung Model Market Trends
3.1.2. Europe Global In Vitro Lung Model Market Trends
3.1.3. Asia Pacific Global In Vitro Lung Model Market Trends
3.1.4. Middle East and Africa Global In Vitro Lung Model Market Trends
3.1.5. South America Global In Vitro Lung Model Market Trends
3.2. Global In Vitro Lung Model Market Dynamics by Region
3.2.1. North America
3.2.1.1. North America Global In Vitro Lung Model Market Drivers
3.2.1.2. North America Global In Vitro Lung Model Market Restraints
3.2.1.3. North America Global In Vitro Lung Model Market Opportunities
3.2.1.4. North America Global In Vitro Lung Model Market Challenges
3.2.2. Europe
3.2.2.1. Europe Global In Vitro Lung Model Market Drivers
3.2.2.2. Europe Global In Vitro Lung Model Market Restraints
3.2.2.3. Europe Global In Vitro Lung Model Market Opportunities
3.2.2.4. Europe Global In Vitro Lung Model Market Challenges
3.2.3. Asia Pacific
3.2.3.1. Asia Pacific Global In Vitro Lung Model Market Drivers
3.2.3.2. Asia Pacific Global In Vitro Lung Model Market Restraints
3.2.3.3. Asia Pacific Global In Vitro Lung Model Market Opportunities
3.2.3.4. Asia Pacific Global In Vitro Lung Model Market Challenges
3.2.4. Middle East and Africa
3.2.4.1. Middle East and Africa Global In Vitro Lung Model Market Drivers
3.2.4.2. Middle East and Africa Global In Vitro Lung Model Market Restraints
3.2.4.3. Middle East and Africa Global In Vitro Lung Model Market Opportunities
3.2.4.4. Middle East and Africa Global In Vitro Lung Model Market Challenges
3.2.5. South America
3.2.5.1. South America Global In Vitro Lung Model Market Drivers
3.2.5.2. South America Global In Vitro Lung Model Market Restraints
3.2.5.3. South America Global In Vitro Lung Model Market Opportunities
3.2.5.4. South America Global In Vitro Lung Model Market Challenges
3.3. PORTER's Five Forces Analysis
3.4. PESTLE Analysis
3.5. Technology Roadmap
3.6. Regulatory Landscape by Region
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Middle East and Africa
3.6.5. South America
3.7. Key Opinion Leader Analysis For Global In Vitro Lung Model Industry
3.8. Analysis of Government Schemes and Initiatives For Global In Vitro Lung Model Industry
3.9. Global In Vitro Lung Model Market Trade Analysis
3.10. The Global Pandemic Impact on Global In Vitro Lung Model Market
4. Global In Vitro Lung Model Market: Global Market Size and Forecast by Segmentation (in USD Mn.) 2025-2032
4.1. Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
4.1.1. 3D Lung Cell Models
4.1.2. 2D Lung Cell Models
4.1.3. Lung-on-a-chip Models
4.1.4. Air–Liquid Interface (ALI) Models
4.2. Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
4.2.1. Drug Discovery & Development
4.2.2. Toxicology & Safety Assessment
4.2.3. Disease Modeling & Mechanism Studies
4.2.4. Precision Medicine & Personalized Therapy
4.2.5. Other Applications
4.3. Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
4.3.1. Pharmaceutical & Biotechnology Companies
4.3.2. Academic & Research Institutes
4.3.3. Contract Research Organizations (CROs)
4.3.4. Medical Device Manufacturers
4.3.5. Others
4.4. Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
4.4.1. Microphysiological Systems (MPS)
4.4.2. Static Cell Cultures
4.4.3. Bioprinting-based Models
4.4.4. Others
4.5. Global In Vitro Lung Model Market Size and Forecast, by Region (2025-2032)
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. Middle East and Africa
4.5.5. South America
5. North America Global In Vitro Lung Model Market Size and Forecast by Segmentation (in USD Mn.) 2025-2032
5.1. North America Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
5.1.1. 3D Lung Cell Models
5.1.2. 2D Lung Cell Models
5.1.3. Lung-on-a-chip Models
5.1.4. Air–Liquid Interface (ALI) Models
5.2. North America Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
5.2.1. Drug Discovery & Development
5.2.2. Toxicology & Safety Assessment
5.2.3. Disease Modeling & Mechanism Studies
5.2.4. Precision Medicine & Personalized Therapy
5.2.5. Other Applications
5.3. North America Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
5.3.1. Pharmaceutical & Biotechnology Companies
5.3.2. Academic & Research Institutes
5.3.3. Contract Research Organizations (CROs)
5.3.4. Medical Device Manufacturers
5.3.5. Others
5.4. North America Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
5.4.1. Microphysiological Systems (MPS)
5.4.2. Static Cell Cultures
5.4.3. Bioprinting-based Models
5.4.4. Others
5.5. North America Global In Vitro Lung Model Market Size and Forecast, by Country (2025-2032)
5.5.1. United States
5.5.1.1. United States Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
5.5.1.1.1. 3D Lung Cell Models
5.5.1.1.2. 2D Lung Cell Models
5.5.1.1.3. Lung-on-a-chip Models
5.5.1.1.4. Air–Liquid Interface (ALI) Models
5.5.1.2. United States Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
5.5.1.2.1. Drug Discovery & Development
5.5.1.2.2. Toxicology & Safety Assessment
5.5.1.2.3. Disease Modeling & Mechanism Studies
5.5.1.2.4. Precision Medicine & Personalized Therapy
5.5.1.2.5. Other Applications
5.5.1.3. United States Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
5.5.1.3.1. Pharmaceutical & Biotechnology Companies
5.5.1.3.2. Academic & Research Institutes
5.5.1.3.3. Contract Research Organizations (CROs)
5.5.1.3.4. Medical Device Manufacturers
5.5.1.3.5. Others
5.5.1.4. United States Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
5.5.1.4.1. Microphysiological Systems (MPS)
5.5.1.4.2. Static Cell Cultures
5.5.1.4.3. Bioprinting-based Models
5.5.1.4.4. Others
5.5.2. Canada
5.5.2.1. Canada Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
5.5.2.1.1. 3D Lung Cell Models
5.5.2.1.2. 2D Lung Cell Models
5.5.2.1.3. Lung-on-a-chip Models
5.5.2.1.4. Air–Liquid Interface (ALI) Models
5.5.2.2. Canada Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
5.5.2.2.1. Drug Discovery & Development
5.5.2.2.2. Toxicology & Safety Assessment
5.5.2.2.3. Disease Modeling & Mechanism Studies
5.5.2.2.4. Precision Medicine & Personalized Therapy
5.5.2.2.5. Other Applications
5.5.2.3. Canada Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
5.5.2.3.1. Pharmaceutical & Biotechnology Companies
5.5.2.3.2. Academic & Research Institutes
5.5.2.3.3. Contract Research Organizations (CROs)
5.5.2.3.4. Medical Device Manufacturers
5.5.2.3.5. Others
5.5.2.4. Canada Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
5.5.2.4.1. Microphysiological Systems (MPS)
5.5.2.4.2. Static Cell Cultures
5.5.2.4.3. Bioprinting-based Models
5.5.2.4.4. Others
5.5.3. Mexico
5.5.3.1. Mexico Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
5.5.3.1.1. 3D Lung Cell Models
5.5.3.1.2. 2D Lung Cell Models
5.5.3.1.3. Lung-on-a-chip Models
5.5.3.1.4. Air–Liquid Interface (ALI) Models
5.5.3.2. Mexico Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
5.5.3.2.1. Drug Discovery & Development
5.5.3.2.2. Toxicology & Safety Assessment
5.5.3.2.3. Disease Modeling & Mechanism Studies
5.5.3.2.4. Precision Medicine & Personalized Therapy
5.5.3.2.5. Other Applications
5.5.3.3. Mexico Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
5.5.3.3.1. Pharmaceutical & Biotechnology Companies
5.5.3.3.2. Academic & Research Institutes
5.5.3.3.3. Contract Research Organizations (CROs)
5.5.3.3.4. Medical Device Manufacturers
5.5.3.3.5. Others
5.5.3.4. Mexico Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
5.5.3.4.1. Microphysiological Systems (MPS)
5.5.3.4.2. Static Cell Cultures
5.5.3.4.3. Bioprinting-based Models
5.5.3.4.4. Others
6. Europe Global In Vitro Lung Model Market Size and Forecast by Segmentation (in USD Mn.) 2025-2032
6.1. Europe Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
6.2. Europe Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
6.3. Europe Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
6.4. Europe Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
6.5. Europe Global In Vitro Lung Model Market Size and Forecast, by Country (2025-2032)
6.5.1. United Kingdom
6.5.1.1. United Kingdom Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
6.5.1.2. United Kingdom Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
6.5.1.3. United Kingdom Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
6.5.1.4. United Kingdom Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
6.5.2. France
6.5.2.1. France Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
6.5.2.2. France Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
6.5.2.3. France Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
6.5.2.4. France Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
6.5.3. Germany
6.5.3.1. Germany Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
6.5.3.2. Germany Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
6.5.3.3. Germany Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
6.5.3.4. Germany Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
6.5.4. Italy
6.5.4.1. Italy Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
6.5.4.2. Italy Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
6.5.4.3. Italy Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
6.5.4.4. Italy Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
6.5.5. Spain
6.5.5.1. Spain Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
6.5.5.2. Spain Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
6.5.5.3. Spain Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
6.5.5.4. Spain Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
6.5.6. Sweden
6.5.6.1. Sweden Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
6.5.6.2. Sweden Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
6.5.6.3. Sweden Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
6.5.6.4. Sweden Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
6.5.7. Austria
6.5.7.1. Austria Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
6.5.7.2. Austria Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
6.5.7.3. Austria Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
6.5.7.4. Austria Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
6.5.8. Rest of Europe
6.5.8.1. Rest of Europe Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
6.5.8.2. Rest of Europe Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
6.5.8.3. Rest of Europe Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
6.5.8.4. Rest of Europe Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7. Asia Pacific Global In Vitro Lung Model Market Size and Forecast by Segmentation (in USD Mn.) 2025-2032
7.1. Asia Pacific Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.2. Asia Pacific Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.3. Asia Pacific Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.4. Asia Pacific Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7.5. Asia Pacific Global In Vitro Lung Model Market Size and Forecast, by Country (2025-2032)
7.5.1. China
7.5.1.1. China Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.5.1.2. China Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.5.1.3. China Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.5.1.4. China Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7.5.2. S Korea
7.5.2.1. S Korea Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.5.2.2. S Korea Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.5.2.3. S Korea Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.5.2.4. S Korea Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7.5.3. Japan
7.5.3.1. Japan Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.5.3.2. Japan Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.5.3.3. Japan Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.5.3.4. Japan Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7.5.4. India
7.5.4.1. India Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.5.4.2. India Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.5.4.3. India Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.5.4.4. India Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7.5.5. Australia
7.5.5.1. Australia Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.5.5.2. Australia Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.5.5.3. Australia Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.5.5.4. Australia Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7.5.6. Indonesia
7.5.6.1. Indonesia Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.5.6.2. Indonesia Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.5.6.3. Indonesia Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.5.6.4. Indonesia Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7.5.7. Malaysia
7.5.7.1. Malaysia Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.5.7.2. Malaysia Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.5.7.3. Malaysia Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.5.7.4. Malaysia Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7.5.8. Vietnam
7.5.8.1. Vietnam Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.5.8.2. Vietnam Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.5.8.3. Vietnam Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.5.8.4. Vietnam Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7.5.9. Taiwan
7.5.9.1. Taiwan Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.5.9.2. Taiwan Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.5.9.3. Taiwan Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.5.9.4. Taiwan Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
7.5.10. Rest of Asia Pacific
7.5.10.1. Rest of Asia Pacific Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
7.5.10.2. Rest of Asia Pacific Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
7.5.10.3. Rest of Asia Pacific Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
7.5.10.4. Rest of Asia Pacific Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
8. Middle East and Africa Global In Vitro Lung Model Market Size and Forecast by Segmentation (in USD Mn.) 2025-2032
8.1. Middle East and Africa Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
8.2. Middle East and Africa Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
8.3. Middle East and Africa Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
8.4. Middle East and Africa Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
8.5. Middle East and Africa Global In Vitro Lung Model Market Size and Forecast, by Country (2025-2032)
8.5.1. South Africa
8.5.1.1. South Africa Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
8.5.1.2. South Africa Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
8.5.1.3. South Africa Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
8.5.1.4. South Africa Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
8.5.2. GCC
8.5.2.1. GCC Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
8.5.2.2. GCC Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
8.5.2.3. GCC Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
8.5.2.4. GCC Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
8.5.3. Nigeria
8.5.3.1. Nigeria Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
8.5.3.2. Nigeria Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
8.5.3.3. Nigeria Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
8.5.3.4. Nigeria Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
8.5.4. Rest of ME&A
8.5.4.1. Rest of ME&A Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
8.5.4.2. Rest of ME&A Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
8.5.4.3. Rest of ME&A Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
8.5.4.4. Rest of ME&A Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
9. South America Global In Vitro Lung Model Market Size and Forecast by Segmentation (in USD Mn.) 2025-2032
9.1. South America Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
9.2. South America Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
9.3. South America Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
9.4. South America Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
9.5. South America Global In Vitro Lung Model Market Size and Forecast, by Country (2025-2032)
9.5.1. Brazil
9.5.1.1. Brazil Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
9.5.1.2. Brazil Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
9.5.1.3. Brazil Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
9.5.1.4. Brazil Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
9.5.2. Argentina
9.5.2.1. Argentina Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
9.5.2.2. Argentina Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
9.5.2.3. Argentina Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
9.5.2.4. Argentina Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
9.5.3. Rest Of South America
9.5.3.1. Rest Of South America Global In Vitro Lung Model Market Size and Forecast, by Model Type (2025-2032)
9.5.3.2. Rest Of South America Global In Vitro Lung Model Market Size and Forecast, by Application (2025-2032)
9.5.3.3. Rest Of South America Global In Vitro Lung Model Market Size and Forecast, by End User (2025-2032)
9.5.3.4. Rest Of South America Global In Vitro Lung Model Market Size and Forecast, by Technology Platform (2025-2032)
10. Company Profile: Key Players
10.1. Epithelix Sàrl
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Scale of Operation (small, medium, and large)
10.1.7. Details on Partnership
10.1.8. Regulatory Accreditations and Certifications Received by Them
10.1.9. Awards Received by the Firm
10.1.10. Recent Developments
10.2. MatTek Corporation
10.3. Lonza
10.4. ATCC (American Type Culture Collection)
10.5. InSphero AG
10.6. Emulate Inc.
10.7. AlveoliX AG
10.8. Mimetas BV
10.9. TissUse GmbH
10.10. CN Bio Innovations Ltd
10.11. PromoCell GmbH
10.12. Charles River Laboratories International Inc.
10.13. Thermo Fisher Scientific Inc.
10.14. Merck KGaA
10.15. SynVivo Inc.
10.16. Hesperos Inc.
10.17. Nortis Inc.
10.18. AxoSim Technologies LLC
10.19. Newcells Biotech
10.20. ImmuONE
10.21. STEMCELL Technologies Inc.
10.22. VITROCELL Systems GmbH
10.23. Kirkstall Ltd
10.24. React4Life Srl
10.25. BEOnChip SL
11. Key Findings
12. Industry Recommendations
13. Global In Vitro Lung Model Market: Research Methodology
14. Terms and Glossary